TABLE 3.
Summary of ELISA for HIV envelope responses prior to challenge with SHIV89.6PD
| Monkey no. | Vaccineb | HIV gp160 titerc |
|---|---|---|
| 2370 | PBjΔnef | 1,600 |
| 2394 | PBjΔnef | 100 |
| 2574 | PBjΔnef | 200 |
| 2580 | PBjΔnef | 400 |
| 2581 | PBjΔnef | 200 |
| 1159 | None | <50 |
| 1235 | None | <50 |
| 343 | 239Δnef | <50 |
| 344 | 239Δnef | <50 |
| 348 | 239Δnef | 400 |
| 354 | 239Δnef | 50 |
| 356 | 239Δnef | <50 |
| RQ1060 | None | <50 |
| RQ1128 | None | <50 |
| RQ1060a | 102,000 | |
| RQ1128a | 409,600 |
a
Sera were collected at 16 weeks after challenge with SHIV89.6PD.
b
PBjΔnef, SIVPBj6.6Δnef; 239Δnef, SIV239Δnef.
c
The reciprocal of the highest serum dilution which is greater than two times the mean pooled preimmunization OD plus two standard deviations of the mean.